Costs to Australian taxpayers of pharmaceutical monopolies and proposals to extend them in the Trans-Pacific Partnership Agreement.

Authors

Deborah H. Gleeson, George Washington University
Hazel Moir
Ruth LopertFollow

Document Type

Journal Article

Publication Date

4-6-2015

Journal

The Medical Journal of Australia

Volume

Volume 202, Issue 6

Issue

6

Inclusive Pages

306-8

Keywords

Commerce; Consumer Participation; Drug Costs; Drug Industry; Intellectual Property; Resource Allocation; Taxes

APA Citation

Gleeson, D.H., Moir, H., Lopert, R. (2015). Costs to Australian taxpayers of pharmaceutical monopolies and proposals to extend them in the Trans-Pacific Partnership Agreement. The Medical Journal of Australia 202(6): 306-8

Peer Reviewed

1